Literature DB >> 9005450

Benzophenanthridine alkaloids of Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non-redox mechanism.

C Vavrecková1, I Gawlik, K Müller.   

Abstract

The benzophenanthridine alkaloids sanguinarine and chelerythrine of Chelidonium majus, L. (Papaveraceae), are potent inhibitors of 5-lipoxygenase in polymorphonuclear leukocytes and 12-lipoxygenase in mouse epidermis, while the activity of soybean lipoxygenase is not influenced. The extract of the herb of Ch.majus also inhibits the 5-LO enzyme. Chelidonine, which cannot form pseudobases, is inactive against LO enzymes. Pro- and antioxidant actions of benzophenanthridine alkaloids can be excluded from the lack of deoxyribose degradation, reactivity against free radicals and inhibition of lipid peroxidation, suggesting that the inhibitory effects against LO enzymes appear to be due to specific enzyme interaction rather than a nonspecific redox mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9005450     DOI: 10.1055/s-2006-957924

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  10 in total

Review 1.  Natural isoquinoline alkaloids: binding aspects to functional proteins, serum albumins, hemoglobin, and lysozyme.

Authors:  Asma Yasmeen Khan; Gopinatha Suresh Kumar
Journal:  Biophys Rev       Date:  2015-11-16

2.  Induction of skeletal muscle contracture and calcium release from isolated sarcoplasmic reticulum vesicles by sanguinarine.

Authors:  C M Hu; H W Cheng; Y W Cheng; J J Kang
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Effect of chelerythrine against endotoxic shock in mice and its modulation of inflammatory mediators in peritoneal macrophages through the modulation of mitogen-activated protein kinase (MAPK) pathway.

Authors:  Weifeng Li; Ting Fan; Yanmin Zhang; Xiaofeng Niu; Wei Xing
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

4.  Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.

Authors:  Yesseny Vasquez-Martinez; Rachana V Ohri; Victor Kenyon; Theodore R Holman; Silvia Sepúlveda-Boza
Journal:  Bioorg Med Chem       Date:  2007-08-22       Impact factor: 3.641

5.  Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.

Authors:  Daniel Habermehl; Bernd Kammerer; René Handrick; Therese Eldh; Charlotte Gruber; Nils Cordes; Peter T Daniel; Ludwig Plasswilm; Michael Bamberg; Claus Belka; Verena Jendrossek
Journal:  BMC Cancer       Date:  2006-01-17       Impact factor: 4.430

6.  Effect of a homeopathic drug, Chelidonium, in amelioration of p-DAB induced hepatocarcinogenesis in mice.

Authors:  Surjyo Jyoti Biswas; Anisur Rahman Khuda-Bukhsh
Journal:  BMC Complement Altern Med       Date:  2002-04-10       Impact factor: 3.659

7.  Alkaloids isolated from natural herbs as the anticancer agents.

Authors:  Jin-Jian Lu; Jiao-Lin Bao; Xiu-Ping Chen; Min Huang; Yi-Tao Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-04       Impact factor: 2.629

8.  Amitozyn impairs chromosome segregation and induces apoptosis via mitotic checkpoint activation.

Authors:  Bastien Hermant; Bastien Herman; Aldrian Gudrun; Anatoly I Potopalsky; Jadwiga Chroboczek; Sergey O Tcherniuk
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

Review 9.  Sanguinaria canadensis: Traditional Medicine, Phytochemical Composition, Biological Activities and Current Uses.

Authors:  Andrew Croaker; Graham J King; John H Pyne; Shailendra Anoopkumar-Dukie; Lei Liu
Journal:  Int J Mol Sci       Date:  2016-08-27       Impact factor: 5.923

Review 10.  The Biological Activity of Natural Alkaloids against Herbivores, Cancerous Cells and Pathogens.

Authors:  Amin Thawabteh; Salma Juma; Mariam Bader; Donia Karaman; Laura Scrano; Sabino A Bufo; Rafik Karaman
Journal:  Toxins (Basel)       Date:  2019-11-11       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.